Skip to content
Sign in
Venture capitalBacked 1 network startup

Dreamward Ventures

Investor in Wink Biotherapeutics' US$75K pre-seed (RNA aptamers); profile is undocumented.

Ticket
—Not published
Assets under management
—
Founded
—
Stages
—
Network startups backed
1
Co-investors
1most often with StartUp Health

How they invest

Unknown; one deal: Wink Biotherapeutics (RNA aptamers for type 1 diabetes and solid tumours).

Stage and ticket

Unknown; small pre-seed cheque (round US$0.075M).

Geography

Unknown.

What makes them say yes

  • Inferred: very early biotech
  • Inferred: small first cheques
  • Unknown

Red flags

  • Unknown
  • Unknown

Sectors

Not published

Stages

Not published

Geographies

Not published

How to approach

Ask Wink Biotherapeutics (also backed by StartUp Health) for an intro.

Portfolio

1 network startup · no other company

One network deal (Wink, May 2025).

Gaps in the portfolio

  • Profile undocumented

Network startups

  • Wink BiotherapeuticsSWC 2026 Finalist

    Preclinical biotech licensing University of Miami RNA aptamers to regenerate beta cells in type 1 diabetes and target solid tumours.

    United States · Biotech & life sciences

    • pre-seed · $75K · 19 May 2025Source

Network startups that fit

3 analysed

San Diego maker of fully defined, serum-free stem cell media that lower cost and variability for iPSC research and biomanufacturing.

US stem-cell culture media with lab customers at pre-seed: early life-science tools.

20%confidence

Evidence from the records

  • “Serum-free culture media for stem cells”
  • “Pre-seed”
Intro path
Wink Biotherapeutics (Dreamward portfolio)
First step
Ask Wink for an intro.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with StartUp Health

Sources